These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13311786)

  • 1. [Thrombotic diseases, especially treatment with tromexan].
    LINDAHL O
    Sven Lakartidn; 1956 Jan; 53(4):185-98. PubMed ID: 13311786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of thromboses and embolisms in obstetrics and gynecology with the liquemin-depot Roche and with tromexan].
    KONIG FE
    Schweiz Med Wochenschr; 1953 Jan; 83(2):40-4. PubMed ID: 13056543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials with a new anticoagulant; tromexan].
    MILANES B; HERNANDEZ A; PEREZ STABLE E
    Rev Cubana Cardiol; 1951; 12(4):141-50. PubMed ID: 12994207
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative evaluation of tromexan and dicumarol in the treatment of thromboembolic conditions--based on experience with 514 patients; a report of the Committee on Anticoagulants of the American Heart Association.
    SCARRONE LA; BECK DF; WRIGHT IS
    Circulation; 1952 Oct; 6(4):489-514. PubMed ID: 12979062
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonistic effect of oral vitamin K1 on the action of ethyl biscoumacetate and phenylindanedione.
    CHALMERS JN; DIXON MF; POLACK W
    Br Med J; 1954 Oct; 2(4894):956-9. PubMed ID: 13199354
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of thrombosis and embolism with the anticoagulants thrombocid and tromexan with special experimental reference to depot thrombocid].
    BELLER FK
    Z Geburtshilfe Gynakol; 1954; 141(2):194-223. PubMed ID: 13227050
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of ethyl biscoumacetate (tromexan).
    VANDER VEER JB; FUNK EH; BOYER FR; KELLER EA
    Am J Med; 1953 Jun; 14(6):694-703. PubMed ID: 13057879
    [No Abstract]   [Full Text] [Related]  

  • 8. Puerperal thrombosis, treatment with tromexan, control of prothrombin activity according to Pedrazzini, Salvidio and F. Koller.
    SCHELLENBERG W
    Praxis; 1953 Jul; 42(29):599-601. PubMed ID: 13088594
    [No Abstract]   [Full Text] [Related]  

  • 9. The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material.
    BRODIE BB; WEINER M; BURNS JJ; SIMSON G; YALE EK
    J Pharmacol Exp Ther; 1952 Dec; 106(4):453-63. PubMed ID: 13023556
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical observations on the use of 3,3'carboxymethylene bis-(4-hydroxycoumarin) ethyl ester (tromexan) in the treatment of venous thrombosis in obstetrics and gynecology].
    SCHIAVINA GP
    Minerva Ginecol; 1953 Feb; 5(3):20-1. PubMed ID: 13063225
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethyl biscoumacetate (tromexan) in coronary artery disease.
    POLLITZER RS
    J S C Med Assoc; 1953 Mar; 49(3):66-8. PubMed ID: 13045283
    [No Abstract]   [Full Text] [Related]  

  • 12. The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.
    BURNS JJ; WEINER M; SIMSON G; BRODIE BB
    J Pharmacol Exp Ther; 1953 May; 108(1):33-41. PubMed ID: 13053419
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulant therapy with tromexan].
    GARCIA TURIELLA R; GASPARY FV; TUERO PR; FERRER J
    Prensa Med Argent; 1953 Aug; 40(32):2093-2103. PubMed ID: 13088693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tromexan therapy of thrombophlebitis].
    VUILLEUMIER P
    Praxis; 1952 Aug; 41(35):758-60. PubMed ID: 13003888
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant therapy; tromexan and G-23350].
    MAROIS A; BROSSEAU C
    Laval Med; 1955 Sep; 20(7):940-51. PubMed ID: 13279212
    [No Abstract]   [Full Text] [Related]  

  • 17. Further pharmacologic aspects of tromexan (pelantan or ethyl biscumacetate).
    GRUBER CM; LEE KS; RIEDERS F
    Arch Int Pharmacodyn Ther; 1952; 90(4):488-97. PubMed ID: 12986946
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of myocardial infarction by dicumarol and its derivatives (tromexan); its biological control].
    DELLA SANTA R
    Helv Med Acta Suppl; 1952; 19(28):1-64. PubMed ID: 13044126
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term treatment of some arteriopathies with tromexan.
    CASTRO CM; STRITZLER G
    Angiology; 1955 Oct; 6(5):442-61. PubMed ID: 13275752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Real or apparent value of tromexan].
    HALSE T
    Dtsch Med Wochenschr; 1952 Dec; 77(52):1634-6. PubMed ID: 13043368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.